(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-c arboxylic acid(CAS: 73384-59-5)

This compound is subject to various regulations including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, as well as FDA and EPA guidelines. It is important to follow specific handling, storage, and disposal protocols to ensure safety and environmental compliance.

Alternatives in synthesis may include various analogs and isomers with similar structures but different functional groups. Common substitute reagents include different amino acids, thiazoles, and triazinyl derivatives, which can be used to modify the chemical structure for specific applications.

The market and research trends for this compound are focused on its potential applications in pharmaceuticals and biotechnology. There is a growing interest in developing new therapeutic agents with improved efficacy and reduced side effects. Additionally, there is ongoing research into the compound's pharmacological properties and potential uses in various medical fields.

Waste containing this compound should be collected and disposed of in accordance with local regulations. It is recommended to use professional waste disposal services to ensure proper incineration or other environmentally safe disposal methods. Adequate precautions should be taken to prevent environmental contamination and ensure worker safety during handling and disposal.